PRESS RELEASE published on 12/11/2023 at 10:00, 2 years 1 month ago Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited
PRESS RELEASE published on 11/20/2023 at 12:00, 2 years 2 months ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000
PRESS RELEASE published on 11/02/2023 at 11:00, 2 years 3 months ago Tryp Therapeutics Inc. Announces Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3.0 Million
PRESS RELEASE published on 10/11/2023 at 22:30, 2 years 3 months ago Tryp Therapeutics Announces Closing of Private Placement of Unsecured Convertible Debentures for Gross Proceeds of AUD$175,000
PRESS RELEASE published on 08/03/2023 at 12:00, 2 years 6 months ago Tryp Therapeutics Announces Jason Carroll as New Chief Executive Officer
PRESS RELEASE published on 08/02/2023 at 12:00, 2 years 6 months ago With Great Sadness Tryp Announces the Passing of David Tousley, Director
PRESS RELEASE published on 07/13/2023 at 12:00, 2 years 6 months ago Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 05/24/2023 at 12:00, 2 years 8 months ago Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 04/27/2023 at 12:00, 2 years 9 months ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Secured Convertible Debentures for Gross Proceeds of AUD$2,400,000
PRESS RELEASE published on 04/12/2023 at 22:00, 2 years 9 months ago Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
Published on 02/05/2026 at 09:05, 2 hours 46 minutes ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 10 hours 16 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 11 hours 51 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 13 hours 26 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/05/2026 at 11:47, 4 minutes ago Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Published on 02/05/2026 at 11:45, 5 minutes ago EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH
Published on 02/05/2026 at 11:30, 21 minutes ago Linde Reports Full-Year and Fourth-Quarter 2025 Results (Earnings Release Tables Attached)
Published on 02/05/2026 at 11:30, 21 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 17 hours 47 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 18 hours 6 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 18 hours 6 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
